| Name | Title | Contact Details |
|---|
All Seasonings Ingredients is a company that provides ingredients, spices, custom blends, and overall solutions for the food service and manufacturing industries.
Marel is the leading global provider of advanced equipment, systems and services to the fish, meat and poultry industries. Our brands – Marel, Stork Poultry Processing and Townsend Further Processing – are among the most respected in the industry and together, we offer the convenience of a single source to meet our customers’ every need. Marel is a multinational company, with over 4,000 employees worldwide. We have offices and subsidiaries in over 30 countries on six continents, a global network of over 100 agents and distributors, and manufacturing facilities in 16 locations worldwide, we work side-by-side with our customers to extend the boundaries of food processing performance. To be the customers’ choice in supplying integrated systems, products and services to the fish, meat and poultry industries.
Artemys Foods is a company on a mission to empower humanity to eat sustainably. We are working on the next generation of meat alternatives by cultivating meat, instead of harvesting meat from animals.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.